1. Home
  2. OPK vs BXC Comparison

OPK vs BXC Comparison

Compare OPK & BXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPK
  • BXC
  • Stock Information
  • Founded
  • OPK 2007
  • BXC 2004
  • Country
  • OPK United States
  • BXC United States
  • Employees
  • OPK N/A
  • BXC N/A
  • Industry
  • OPK Biotechnology: Pharmaceutical Preparations
  • BXC Wholesale Distributors
  • Sector
  • OPK Health Care
  • BXC Consumer Discretionary
  • Exchange
  • OPK Nasdaq
  • BXC Nasdaq
  • Market Cap
  • OPK 1.0B
  • BXC 669.0M
  • IPO Year
  • OPK 1995
  • BXC 2004
  • Fundamental
  • Price
  • OPK $1.40
  • BXC $77.88
  • Analyst Decision
  • OPK Buy
  • BXC Strong Buy
  • Analyst Count
  • OPK 4
  • BXC 3
  • Target Price
  • OPK $2.75
  • BXC $91.00
  • AVG Volume (30 Days)
  • OPK 1.9M
  • BXC 88.1K
  • Earning Date
  • OPK 11-06-2025
  • BXC 10-28-2025
  • Dividend Yield
  • OPK N/A
  • BXC N/A
  • EPS Growth
  • OPK N/A
  • BXC N/A
  • EPS
  • OPK N/A
  • BXC 3.42
  • Revenue
  • OPK $664,029,000.00
  • BXC $2,947,258,000.00
  • Revenue This Year
  • OPK N/A
  • BXC $2.01
  • Revenue Next Year
  • OPK $0.84
  • BXC $4.48
  • P/E Ratio
  • OPK N/A
  • BXC $22.90
  • Revenue Growth
  • OPK N/A
  • BXC N/A
  • 52 Week Low
  • OPK $1.11
  • BXC $63.14
  • 52 Week High
  • OPK $2.04
  • BXC $134.79
  • Technical
  • Relative Strength Index (RSI)
  • OPK 53.38
  • BXC 50.93
  • Support Level
  • OPK $1.34
  • BXC N/A
  • Resistance Level
  • OPK $1.44
  • BXC $82.64
  • Average True Range (ATR)
  • OPK 0.04
  • BXC 2.72
  • MACD
  • OPK -0.00
  • BXC -3.65
  • Stochastic Oscillator
  • OPK 60.00
  • BXC 88.70

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

About BXC Bluelinx Holdings Inc.

BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.

Share on Social Networks: